BM
RETA

Bridger Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bridger Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,800
Closed -$2.53M – 36
2023
Q2 		$2.53M Hold
24,800
– – 0.84% 25
2023
Q1 		$2.25M Buy
+24,800
New +$2.25M 0.84% 21